New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-t...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Feb. 26, 2021 /PRNewswire-AsiaNet / -- MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosingInitial f...
Authors: LATEST ASIANET NEWS RELEASES